North Dakota is the latest state to put a hard limit on what people with diabetes pay for insulin — $25 a month, no matter the deductible. It is now one of 29 states with an insulin out-of-pocket cap, and the movement behind the caps is one of the rare health care fights drawing support from both parties.
How the caps started
Colorado was first, in 2019, capping what state-regulated health plans can charge patients at $100 for a 30-day supply of insulin. Other states followed with their own versions, and North Dakota's law — co-sponsored by Republican state Sen. Sean Cleary and championed for years by Democratic state Sen. Tim Mathern — passed last year with overwhelming bipartisan support. The push came from families like the Kritzbergers of Hillsboro, North Dakota, whose 17-year-old daughter Nina has Type 1 diabetes. Despite having insurance, the family pays at least $8,000 a year out of pocket for drugs, supplies, and medical appointments.
The caps work by limiting what a patient pays each month for insulin, even if the plan has a high deductible that would otherwise force the patient to pay thousands before coverage kicks in for other care. For people who depend on insulin, that matters every single day: a missed dose can send someone to the hospital.
Why insulin got so expensive
About a fifth of the estimated 40 million Americans with diabetes depend on insulin, a drug that has been in use for about a century. But steep price hikes over the past decade pushed patients' out-of-pocket costs to an average of $470 a year in 2018 for people with private health insurance, according to federal data. Prices have eased since then as drug companies faced public backlash — average yearly out-of-pocket costs for people with private insurance fell to $220 in 2025 — but families still ration insulin, sometimes with deadly consequences, and patient advocates say a cap is the only protection against the next price spike.
The politics have shifted with the prices. Insurers and business groups argued in North Dakota that price relief for people with diabetes would mean higher premiums for everyone else. But supporters showed lawmakers that a similar cap for state employees had little impact on premiums, and many lawmakers — including Republicans — had grown frustrated with drugmakers and insurers. "Why are folks paying hundreds of dollars a month for a drug that's been commercially available for decades?" Cleary asked. About 7 in 10 U.S. adults — including 68% of Republicans and 77% of Democrats — said in a KFF survey earlier this year that there isn't enough government regulation to limit the price of prescription drugs.
What the caps don't do
A state cap is not a cure-all, and shoppers should know its limits before counting on it:
- It only reaches state-regulated plans. Health insurance provided by larger employers is typically regulated by the federal government, so a state cap may not apply to your plan even if you live in a cap state.
- It covers insulin — not the rest of the bill. Pumps, glucose monitors, test strips, and doctor visits are separate costs, and families like the Kritzbergers still pay thousands a year even with a cap in place.
- The cap amount varies by state. North Dakota's is $25 a month; Colorado's is $100 for a 30-day supply. Check your own state's rule before assuming a number.
- It doesn't set the price of the drug. The cap limits what the patient pays out of pocket — the underlying price, and what the plan pays, is a separate fight.
Congress is now considering a national insulin cap, with bipartisan co-sponsors including North Dakota Republican Sen. Kevin Cramer. Until then, the state caps are the main protection — and they are only as good as the plan you hold.
The bottom line: 29 states now cap insulin out of pocket, and the caps are real relief for people on state-regulated plans — but they don't reach every plan and they don't cover the rest of the diabetes bill. If insulin or another daily prescription is part of your life, the drug coverage on your 2027 plan deserves the same hard look as the premium, before the December 15 deadline for January 1 coverage.
This article is general information, not advice about your specific situation.